Hiroshima, Japan

Taishi Tanaka

This inventor holds 3 USPTO granted patents and 3 published patent applications and 3 EPO patents. Top assignees: Medrx Co., Ltd, Yanmar Holdings Co., Ltd.. Active years: 2018-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Taishi Tanaka. Retrieved from https://idiyas.com/inventor/taishi-tanaka

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.2

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Tokyo, JP (2018)
  • Hiroshima, JP (2020)

Company Filing History:


Years Active: 2018-2026

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Taishi Tanaka: Innovator in Microneedle Technology

Introduction

Taishi Tanaka is a prominent inventor based in Hiroshima, Japan. He has made significant contributions to the field of microneedle technology, focusing on drug delivery systems. With a total of 3 patents, his work is paving the way for advancements in medical applications.

Latest Patents

Tanaka's latest patents include innovative designs for microneedle arrays. One of his notable inventions is a microneedle array coated with a drug composition. This invention features a pin frog shape and is designed to administer drugs with high quantitative performance, even at low content. Another significant patent involves a microneedle and microneedle array that allows for easy, safe, and efficient drug injection into the skin's surface layer.

Career Highlights

Taishi Tanaka is currently associated with Medrx Co., Ltd., where he continues to develop cutting-edge technologies in drug delivery. His work is instrumental in enhancing the effectiveness of medical treatments through innovative delivery methods.

Collaborations

Tanaka collaborates with talented individuals in his field, including Kiyotsuna Toyohara and Masaki Ishibashi. Their combined expertise contributes to the advancement of microneedle technology.

Conclusion

Taishi Tanaka's contributions to microneedle technology are noteworthy and have the potential to revolutionize drug delivery systems. His innovative patents reflect a commitment to improving healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…